Advertisement

Gastric Lymphoma

  • Hongbo Yu
  • Xiangshan Fan
Chapter

Abstract

Non-Hodgkin lymphoma in the gastric cardia is mostly lowgrade with a predominance of marginalzone B-cell lymphoma, also known as MALToma, which is primarily related to H. pylori infection. In contrast, highgrade lymphoma in this region is uncommon, occurs mainly in the elderly population, and shows high heterogeneity in cell types and prognosis. Therefore, accurate morphologic pathologic diagnosis and molecular characterization is essential for patient management.

Keywords

Stomach Non-Hodgkin lymphoma Marginalzone lymphoma Diffuse large B-cell lymphoma Cancer H. pylori 

References

  1. 1.
    Koch P, del Valle F, Berdel WE, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol. 2001;19:3861–73.CrossRefPubMedGoogle Scholar
  2. 2.
    Papaxoinis G, Papageorgiou S, Rontogianni D, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG). Leuk Lymphoma. 2006;47:2140–6.CrossRefPubMedGoogle Scholar
  3. 3.
    Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;29:252–60.CrossRefPubMedGoogle Scholar
  4. 4.
    Cogliatti SB, Schmid U, Schumacher U, et al. Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology. 1991;101:1159–70.CrossRefPubMedGoogle Scholar
  5. 5.
    Radaszkiewicz T, Dragosics B, Bauer P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology. 1992;102:1628–38.CrossRefPubMedGoogle Scholar
  6. 6.
    Muller AF, Maloney A, Jenkins D, et al. Primary gastric lymphoma in clinical practice 1973-1992. Gut. 1995;36:679–83.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Wang T, Gui W, Shen Q. Primary gastrointestinal non-Hodgkin’s lymphoma: clinicopathological and prognostic analysis. Med Oncol. 2010;27:661–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Chung KM, Chang ST, Huang WT, et al. Bcl-6 expression and lactate dehydrogenase level predict prognosis of primary gastric diffuse large B-cell lymphoma. J Formos Med Assoc. 2013;112:382–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Nakamura S, Ye H, Bacon CM, et al. Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma. Clin Cancer Res. 2008;14:3002–10.CrossRefPubMedGoogle Scholar
  10. 10.
    Loghavi S, Alayed K, Aladily TN, et al. Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients. J Hematol Oncol. 2015;8:65.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Tio TL, den Hartog Jager FC, Tijtgat GN. Endoscopic ultrasonography of non-Hodgkin lymphoma of the stomach. Gastroenterology. 1986;91:401–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Caletti G, Ferrari A, Brocchi E, Barbara L. Accuracy of endoscopic ultrasonography in the diagnosis and staging of gastric cancer and lymphoma. Surgery. 1993;113:14–27.PubMedGoogle Scholar
  13. 13.
    Fujishima H, Misawa T, Maruoka A, Chijiiwa Y, Sakai K, Nawata H. Staging and follow-up of primary gastric lymphoma by endoscopic ultrasonography. Am J Gastroenterol. 1991;86:719–24.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Suekane H, Iida M, Yao T, Matsumoto T, Masuda Y, Fujishima M. Endoscopic ultrasonography in primary gastric lymphoma: correlation with endoscopic and histologic findings. Gastrointest Endosc. 1993;39:139–45.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Fischbach W, Goebeler-Kolve ME, Greiner A. Diagnostic accuracy of EUS in the local staging of primary gastric lymphoma: results of a prospective, multicenter study comparing EUS with histopathologic stage. Gastrointest Endosc. 2002;56:696–700.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Wiersema MJ, Gatzimos K, Nisi R, Wiersema LM. Staging of non-Hodgkin’s gastric lymphoma with endosonography-guided fine-needle aspiration biopsy and flow cytometry. Gastrointest Endosc. 1996;44:734–6.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Wotherspoon AC, Doglioni C, Isaacson PG. Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT): a multifocal disease. Histopathology. 1992;20:29–34.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Chang KJ, Katz KD, Durbin TE, et al. Endoscopic ultrasound-guided fine-needle aspiration. Gastrointest Endosc. 1994;40:694–9.PubMedPubMedCentralGoogle Scholar
  19. 19.
    Wiersema MJ, Kochman ML, Cramer HM, Tao LC, Wiersema LM. Endosonography-guided real-time fine-needle aspiration biopsy. Gastrointest Endosc. 1994;40:700–7.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Vilmann P, Hancke S, Henriksen FW, Jacobsen GK. Endoscopic ultrasonography-guided fine-needle aspiration biopsy of lesions in the upper gastrointestinal tract. Gastrointest Endosc. 1995;41:230–5.CrossRefPubMedGoogle Scholar
  21. 21.
    Suekane H, Iida M, Kuwano Y, et al. Diagnosis of primary early gastric lymphoma. Usefulness of endoscopic mucosal resection for histologic evaluation. Cancer. 1993;71:1207–13.CrossRefPubMedGoogle Scholar
  22. 22.
    Papageorgiou SG, Sachanas S, Pangalis GA, et al. Gastric involvement in patients with primary mediastinal large B-cell lymphoma. Anticancer Res. 2014;34:6717–23.PubMedGoogle Scholar
  23. 23.
    Erbersdobler A, Petri S, Lock G. Russell body gastritis: an unusual, tumor-like lesion of the gastric mucosa. Arch Pathol Lab Med. 2004;128:915–7.PubMedGoogle Scholar
  24. 24.
    Di Bernardo A, Mussetti A, Aiello A, De Paoli E, Cabras AD. Alternate clonal dominance in richter transformation presenting as extranodal diffuse large B-cell lymphoma and synchronous classic Hodgkin lymphoma. Am J Clin Pathol. 2014;142:227–32.CrossRefPubMedGoogle Scholar
  25. 25.
    Huang X, Zhang Y, Gao Z. Plasmablastic lymphoma of the stomach with C-MYC rearrangement in an immunocompetent young adult: a case report. Medicine (Baltimore). 2015;94:e470.CrossRefGoogle Scholar
  26. 26.
    He M, Chen K, Li S, et al. Clinical Significance of “Double-hit” and “Double-protein” expression in Primary Gastric B-cell Lymphomas. J Cancer. 2016;7:1215–25.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Starostik P, Patzner J, Greiner A, et al. Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood. 2002;99:3–9.CrossRefPubMedGoogle Scholar
  28. 28.
    Sumida T, Kitadai Y, Masuda H, et al. Rapid progression of Epstein-Barr-virus-positive gastric diffuse large B-cell lymphoma during chemoradiotherapy: a case report. Clin J Gastroenterol. 2008;1:105–9.CrossRefPubMedGoogle Scholar
  29. 29.
    McManus DT, Catherwood MA, Carey PD, Cuthbert RJ, Alexander HD. ALK-positive diffuse large B-cell lymphoma of the stomach associated with a clathrin-ALK rearrangement. Hum Pathol. 2004;35:1285–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Rudzki Z, Rucinska M, Jurczak W, et al. ALK-positive diffuse large B-cell lymphoma: two more cases and a brief literature review. Pol J Pathol. 2005;56:37–45.PubMedGoogle Scholar
  31. 31.
    Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–90.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Chen Y, Xiao L, Zhu X, et al. [Immunohistochemical classification and prognosis of diffuse large B-cell lymphoma in China]. Zhonghua Bing Li Xue Za Zhi. 2014;43:383–8.Google Scholar
  33. 33.
    Martin-Arruti M, Vaquero M, Diaz de Otazu R, et al. Bcl-2 and BLIMP-1 expression predict worse prognosis in gastric diffuse large B cell lymphoma (DLCBL) while other markers for nodal DLBCL are not useful. Histopathology. 2012;60:785–92.CrossRefPubMedGoogle Scholar
  34. 34.
    Kuo SH, Yeh KH, Chen LT, et al. Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity. Blood Cancer J. 2014;4:e220.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Yoshino T, Nakamura S, Matsuno Y, et al. Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma. Cancer Sci. 2006;97:163–6.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Pathology and Laboratory MedicineVA Boston Healthcare SystemWest RoxburyUSA
  2. 2.Harvard Medical School, Brigham and Women’s HospitalBostonUSA
  3. 3.Department of PathologyThe Affiliated Drum Tower Hospital, Nanjing University Medical SchoolNanjing, JiangsuPeople’s Republic of China

Personalised recommendations